Assessing differential effects of single and accelerated low‐frequency rTMS to the visual cortex on GABA and glutamate concentrations
Open Access
- 23 September 2020
- journal article
- research article
- Published by Wiley in Brain and Behavior
- Vol. 10 (12)
Abstract
Background The application of repetitive transcranial magnetic stimulation (rTMS) for therapeutic use in visual‐related disorders and its underlying mechanisms in the visual cortex is under‐investigated. Additionally, there is little examination of rTMS adverse effects particularly with regards to visual and cognitive function. Neural plasticity is key in rehabilitation and recovery of function; thus, effective therapeutic strategies must be capable of modulating plasticity. Glutamate and γ‐aminobutyric acid (GABA)‐mediated changes in the balance between excitation and inhibition are prominent features in visual cortical plasticity. Objectives and method: We investigated the effects of low‐frequency (1 Hz) rTMS to the visual cortex on altering levels of neurotransmitters GABA and glutamate to determine the therapeutic potential of 1 Hz rTMS for visual‐related disorders. Two rTMS regimes commonly used in clinical applications were investigated: participants received rTMS to the visual cortex either in a single 20‐min session or five accelerated 20‐min sessions (not previously investigated at the visual cortex). Proton (1H) magnetic resonance spectroscopy for in vivo quantification of GABA (assessed via GABA+) and glutamate (assessed via Glx) concentrations was performed pre‐ and post‐rTMS. Results: GABA+ and Glx concentrations were unaltered following a single session of rTMS to the visual cortex. One day of accelerated rTMS significantly reduced GABA+ concentration for up to 24 hr, with levels returning to baseline by 1‐week post‐rTMS. Basic visual and cognitive function remained largely unchanged. Conclusion: Accelerated 1 Hz rTMS to the visual cortex has greater potential for approaches targeting plasticity or in cases with altered GABAergic responses in visual disorders. Notably, these results provide preliminary insight into a critical window of plasticity with accelerated rTMS (e.g., 24 hr) in which adjunct therapies may offer better functional outcome. We describe detailed procedures to enable further exploration of these protocols.Keywords
Funding Information
- Canada Foundation for Innovation (12807)
- Natural Sciences and Engineering Research Council of Canada (327588)
This publication has 121 references indexed in Scilit:
- In vivo magnetic resonance spectroscopy of GABA: A methodological reviewProgress in Nuclear Magnetic Resonance Spectroscopy, 2012
- In vivo detection of GABA and glutamate with MEGA‐PRESS: Reproducibility and gender effectsJournal of Magnetic Resonance Imaging, 2011
- GABAB receptor modulation of synaptic functionCurrent Opinion in Neurobiology, 2011
- The Role of GABA in Human Motor LearningCurrent Biology, 2011
- Accelerated repetitive transcranial magnetic stimulation for treatment-resistant depressionDepression and Anxiety, 2010
- Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and researchClinical Neurophysiology, 2009
- A Review of Combined TMS-EEG Studies to Characterize Lasting Effects of Repetitive TMS and Assess Their Usefulness in Cognitive and Clinical NeuroscienceBrain Topography, 2009
- State-Dependency of Transcranial Magnetic StimulationBrain Topography, 2008
- GABAA receptors and alcoholPharmacology Biochemistry and Behavior, 2008
- Focal electrical stimulation as a sham control for repetitive transcranial magnetic stimulation: Does it truly mimic the cutaneous sensation and pain of active prefrontal repetitive transcranial magnetic stimulation?Brain Stimulation, 2008